Press release
Glioblastoma Multiforme Treatment Market: Size, Share, Trends, and Forecast (2025-2034)
The glioblastoma multiforme (GBM) treatment market addresses one of the most aggressive and deadly forms of brain cancer. GBM accounts for the majority of malignant primary brain tumors in adults, characterized by rapid growth, high recurrence rates, and poor prognosis. The standard treatment typically includes surgery, radiotherapy, and chemotherapy; however, advancements in targeted therapy, immunotherapy, and precision medicine are expanding the therapeutic landscape.
Get a free sample report: https://bit.ly/3J3PTtf
In 2024, the global glioblastoma multiforme treatment market was valued at USD 2.49 billion. Growth is being driven by the rising incidence of brain tumors worldwide, technological advancements in neuro-oncology, and the introduction of novel drug delivery methods to overcome the blood-brain barrier. Between 2025 and 2034, the market is projected to grow at a CAGR of 8.40%, reaching USD 5.58 billion.
Glioblastoma Multiforme Treatment Market Size & Share
The GBM treatment market is dominated by developed regions due to better diagnostic capabilities, high healthcare spending, and wider access to advanced treatment options.
Market Share by Region (2024):
North America: ~45% - Driven by advanced research facilities, strong regulatory frameworks, and a high prevalence of GBM.
Europe: ~30% - Supported by national healthcare systems and robust clinical trial networks.
Asia-Pacific: ~20% - Fastest-growing region, benefiting from improved cancer diagnostics and growing awareness.
Rest of the World: ~5% - Expansion led by emerging healthcare infrastructure.
Market Share by Treatment Type (2024):
Surgery & Radiotherapy: ~55%
Chemotherapy: ~25%
Targeted Therapy & Immunotherapy: ~20% - Expected to grow significantly due to clinical trial success rates.
Market Dynamics & Trends
Key Growth Drivers
Increasing Incidence of Brain Tumors: Rising cases of GBM due to aging populations and improved diagnostic imaging.
Advancements in Drug Delivery Systems: Technologies that penetrate the blood-brain barrier are enabling more effective treatments.
Precision Medicine: Genetic profiling of tumors for personalized therapy.
Government and Private Funding: Increased investment in cancer research and clinical trials.
Emerging Trends
Immunotherapy Adoption: Use of immune checkpoint inhibitors and CAR-T cell therapies for GBM.
Tumor-Treating Fields (TTF): Non-invasive therapy gaining traction as an adjunct treatment.
Gene Therapy: Targeting tumor-specific mutations to slow progression.
Combination Therapies: Integrating radiotherapy, chemotherapy, and targeted agents for better survival rates.
Restraining Factors
Poor Prognosis: Median survival remains 12-15 months despite treatment.
High Treatment Costs: Advanced therapies can be expensive, limiting accessibility.
Therapy Resistance: GBM cells often develop resistance to current treatments.
Growth Outlook of the Glioblastoma Multiforme Treatment Market
From 2025 to 2034, the GBM treatment market is forecast to nearly double, driven by:
Breakthrough drug approvals.
Expansion of clinical trials in emerging markets.
Adoption of AI-assisted diagnostic and treatment planning.
Growing integration of liquid biopsy for early detection and recurrence monitoring.
The Asia-Pacific region is expected to post the fastest CAGR due to infrastructure development, government-led cancer control programs, and foreign investment in clinical research.
Read full report with table of content: https://bit.ly/4lgN9WE
Market Opportunities and Challenges
Opportunities
Development of Novel Immunotherapies: Increasing investment in checkpoint inhibitors and cancer vaccines.
Orphan Drug Designations: Regulatory incentives for rare diseases such as GBM.
Emerging Market Expansion: Rising healthcare expenditure in Asia, Latin America, and the Middle East.
AI & Machine Learning in Neuro-Oncology: Improving diagnosis, treatment planning, and survival prediction.
Challenges
Clinical Trial Complexity: Recruitment is challenging due to the rarity and severity of GBM.
Blood-Brain Barrier: Limits drug penetration, reducing treatment efficacy.
High Relapse Rate: GBM almost invariably recurs despite initial treatment success.
Recent Developments in the Market
Merck & Co., Inc. continued clinical trials for pembrolizumab in GBM patients with promising early results.
F. Hoffmann-La Roche Ltd expanded its oncology portfolio with targeted therapy trials.
Pfizer Inc. invested in novel small molecule inhibitors designed to cross the blood-brain barrier.
Amgen Inc. initiated studies on combination immunotherapies for recurrent GBM.
Arbor Pharmaceuticals advanced its pipeline in CNS oncology drugs.
Competitor Analysis
The GBM treatment market features both large multinational pharmaceutical companies and smaller biotech firms specializing in oncology. The competitive environment is shaped by patent portfolios, clinical trial progress, and strategic partnerships.
Key Players
Arbor Pharmaceuticals
Focused on CNS disorders, developing therapeutic options for rare neurological cancers like GBM.
Bristol-Myers Squibb
Leader in immuno-oncology, particularly with immune checkpoint inhibitors targeting GBM.
Eli Lilly and Company
Investing in targeted therapies and novel agents for brain tumors.
F. Hoffmann-La Roche Ltd
Renowned for oncology innovation, actively engaged in GBM-specific clinical research.
Merck & Co. Inc.
Developer of pembrolizumab, exploring its potential in glioblastoma treatment.
Sun Pharmaceutical Industries Ltd.
Expanding its oncology portfolio with a focus on affordable chemotherapy agents.
Lanthen Pharmaceutical
A biotech innovator focusing on niche cancer treatments, including GBM.
Pfizer Inc.
Advancing precision medicine and novel targeted agents for GBM.
Amgen Inc.
Working on combination immunotherapies and targeted biological agents.
Teva Pharmaceutical Industries Ltd.
Offers generic oncology drugs and supportive care medicines for GBM patients.
FAQs about the Glioblastoma Multiforme Treatment Market
Q. What is glioblastoma multiforme?
Glioblastoma multiforme is an aggressive brain tumor with a high recurrence rate and poor prognosis.
Q. What is driving the GBM treatment market?
Rising brain tumor incidence, technological advances in therapy, and increased R&D investment.
Q. Which region dominates the market?
North America leads, followed by Europe, due to advanced healthcare systems and research infrastructure.
Q. What treatments are currently used for GBM?
Surgery, radiotherapy, chemotherapy, targeted therapy, and emerging immunotherapies.
Q. What is the forecast for 2034?
The market is expected to reach USD 5.58 billion, growing at a CAGR of 8.40%.
Find More Blog:
Epigenomics Market: https://bit.ly/45fzoCX
Cryotherapy Market: https://bit.ly/4lFHr1C
Clinical IT Market: https://bit.ly/44ILPam
Precision Medicine Market: https://bit.ly/4f1WNLl
Epigenetics Market: https://bit.ly/3GWY8Xm
Media Contact:
Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioblastoma Multiforme Treatment Market: Size, Share, Trends, and Forecast (2025-2034) here
News-ID: 4137783 • Views: …
More Releases from Expert Market Research
Colposcopes Market: Market Growth, and Demand Forecast 2025-2034
Overview of the Colposcopes Market
The colposcopes market plays a critical role in women's healthcare, especially in the early detection and diagnosis of cervical cancer, precancerous lesions, and other gynecological conditions. A colposcope is a specialized diagnostic device used during colposcopy procedures to visually examine the cervix, vagina, and vulv for abnormalities.
Get a free sample report: https://bit.ly/4fF5An3
With the rising burden of cervical cancer worldwide, colposcopes have become indispensable tools in gynecological…
Saxagliptin Market: Trends Analysis, and Demand Forecast (2025-2034)
Overview of the Saxagliptin Market
The saxagliptin market is positioned for notable growth during the forecast period of 2025-2034, primarily driven by the rising global prevalence of type 2 diabetes mellitus (T2DM). Saxagliptin, a DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor), is widely prescribed either as a standalone therapy or in combination with other antidiabetic drugs to control blood sugar levels.
Get a free sample report: https://bit.ly/4fK7jaA
Type 2 diabetes has become one of the…
Proctoscope Market: Demand Forecast and Future (2025-2034)
Overview of the Proctoscope Market
The proctoscope market is poised for substantial growth over the next decade, supported by increasing cases of colorectal diseases, advancements in medical diagnostic tools, and the expansion of global colorectal cancer screening programs. A proctoscope is a medical instrument designed to examine the rectu and lower part of the colon, playing a critical role in the diagnosis and treatment of conditions such as hemorrhoids, anal fissures,…
Tocopherols Market: Market Expansion, and Demand Forecast (2025-2034)
Overview of the Tocopherols Market
The tocopherols market is experiencing significant growth as consumers and industries increasingly turn to natural antioxidants for health, wellness, and cosmetic applications. Tocopherols, a class of chemical compounds with vitamin E activity, are derived primarily from vegetable oils such as soybean, sunflower, and corn oils. Known for their antioxidant, anti-aging, and preservative properties, they play a crucial role in the food, pharmaceutical, cosmetic, and animal feed…
More Releases for GBM
Glioblastoma Multiforme (GBM) Treatment Market Report 2024: Trends and Projectio …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Glioblastoma Multiforme (GBM) Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.66 billion In…
Goodpasture Syndrome (Anti-GBM Disease) With Excellent CAGR 5.30%
Goodpasture Syndrome Treatment market analysis report is a professional and a detailed market study focusing on primary and secondary drivers, market share, leading segments, and geographical analysis. This market report is a comprehensive background analysis of the ABC industry, which includes an assessment of the parental market. The report also aids in prioritizing market goals and attain profitable business. This analysis gives an examination of various segments that are relied…
Anti-GBM Autoantibody Disease Market - Embracing Immune Harmony: Anti-GBM Autoan …
Newark, New Castle, USA - new report, titled Anti-GBM Autoantibody Disease Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-GBM Autoantibody Disease market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-GBM Autoantibody Disease market. The report offers an overview of…
Glioblastoma Multiforme Treatment (GBM) Market: Trends, Opportunities & Regional …
The global glioblastoma multiforme treatment market is anticipated to rise significantly owing to key players adopting competitive strategies such as merger and acquisitions for marketing. According to a report by Transparency Market Research, the key players in the global glioblastoma multiforme treatment are adopting strategies such as development of biological drugs that helps in reducing the side effects in the patients which are caused due to consuming chemotherapeutic agents and…
Understanding Impact of COVID-19 on Glioblastoma Multiforme (GBM) Market
Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS)…
2019 - 2025 Glioblastoma Multiforme Treatment Market | GBM Market
Global Glioblastoma Multiforme Treatment Market, Its Market Trends And Analysis
Glioblastoma multiforme is the high-grade glioma and potent malignant brain tumor that affects glial cells. Glioblastoma multiforme contains the complexly differentiated neoplastic astrocytes which are the subtype of central nervous system. Glioblastoma multiforme is different from the anaplastic astrocytoma due to the presence of hyperplastic blood vessels and necrotic tissue.
Request Sample Report:
https://precisionbusinessinsights.com/request-sample?product_id=16248
The global glioblastoma multiforme treatment market is…
